Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Paul Larson
Sponsor
Aspen Neuroscience
Unit
Neurosurgery